Q2i wins Gold Stevie for technology innovation, CEO Steve Jenkins takes Silver

By AI, Created 11:34 AM UTC, May 20, 2026, /AGP/ – Q2i won a Gold Stevie Award in the 2026 American Business Awards for technology innovation, while Founder and CEO Steve Jenkins earned a Silver Stevie in the entrepreneur category. The honors spotlight the Boston digital health company’s push to turn behavioral science research into scalable platforms for healthcare and public-sector use.

Why it matters: - The awards put Q2i’s evidence-based digital health model in the spotlight at a time when healthcare buyers are demanding measurable outcomes, stronger engagement and scalable deployment. - The recognition also lifts Steven Jenkins’ profile as a founder building commercial products from research-backed technology. - Q2i’s work spans behavioral health, substance use disorder treatment, chronic disease prevention and community supervision, giving the company reach across regulated care and public-sector settings.

What happened: - Q2i said it won the Gold Stevie Award for Achievement in Technology Innovation in the 24th Annual American Business Awards. - Steven Jenkins, Q2i’s Founder and Chief Executive Officer, won a Silver Stevie Award in the Entrepreneur Awards – Health Products & Services category. - The awards will be presented at a gala ceremony at the Marriott Marquis Hotel in New York on Tuesday, June 9. - More than 230 professionals worldwide took part in judging this year’s Stevie Award winners.

The details: - Q2i was recognized for its nomination, “Q2i: Translating Research into Evidence-Based, Scalable Digital Health Platforms with Real-World Impact.” - The company’s platforms are designed to improve engagement, adherence and outcomes across behavioral health and chronic disease. - Q2i said its solutions are deployed across multiple statewide and public-sector programs. - The company’s products are built to translate behavioral science into practical, secure and scalable systems for real-world use. - Q2i said its portfolio includes platforms supporting behavioral health, substance use disorder treatment, chronic disease prevention and community supervision. - The company said the platforms were developed and validated through NIH-funded research. - Q2i said the systems are designed for regulated healthcare and public-sector environments where security, fidelity and measurable outcomes matter. - Judges praised Q2i for translating rigorous research into commercially viable digital health platforms with measurable real-world impact. - Jenkins’ Silver Stevie recognized his leadership in building Q2i into a high-growth digital health company focused on commercializing evidence-based technology for healthcare and public-sector markets. - Under Jenkins’ leadership, Q2i has moved from research-backed product development to large-scale deployments supporting state agencies, healthcare organizations and public-sector partners.

Between the lines: - The dual awards suggest the judges saw both product strength and leadership execution as part of the same story. - Q2i is positioning itself around a common pain point in digital health: turning promising research into tools that can actually be used at scale in real systems. - The emphasis on public-sector deployment and NIH-funded validation signals a company aiming for credibility in markets where procurement, compliance and outcomes are closely scrutinized. - Stevie Awards president Maggie Miller said the 2026 nominations reflected a dynamic and competitive U.S. business environment, and congratulated this year’s winners.

What’s next: - Q2i and Jenkins are set to be honored at the June 9 awards gala in New York. - The recognition may help Q2i in future sales and partnership discussions with health systems, payers and government agencies. - The company is likely to continue emphasizing evidence-based product development as it expands deployments across healthcare and public-sector markets.

The bottom line: - Q2i’s Gold Stevie and Jenkins’ Silver Stevie reinforce the company’s pitch that research-backed digital health can be both commercially viable and operationally useful at scale.